Viewing Study NCT02034006


Ignite Creation Date: 2025-12-26 @ 4:03 PM
Ignite Modification Date: 2026-03-02 @ 3:43 PM
Study NCT ID: NCT02034006
Status: COMPLETED
Last Update Posted: 2019-02-18
First Post: 2014-01-09
Is NOT Gene Therapy: True
Has Adverse Events: True

Brief Title: A Study of the Criteria Establishing the Need for Re-treatment With Ranibizumab Upon Relapse in Patients With Visual Impairment Due to Choroidal Neovascularization Secondary to Pathologic Myopia.
Sponsor:
Organization: